Original Article in The Daily Camera
Two Boulder stealth-mode startups recently each raised more than $1 million in equity funding, according to Securities and Exchange Commission filings made Monday.
Collective IP, a firm specializing in intellectual property analytics and information, raised nearly $1.05 million and Sinopsys Surgical Inc., a medical device firm formerly known as DCS Surgical, raised at least $1.2 million, the companies’ respective regulatory filings show.
Collective IP, formerly IPfolio LLC, is a firm in private beta that is headed by Adam Rubenstein, a venture capitalist and active member of Boulder’s biotech and startup scenes. Rubenstein’s firm is in private beta, but a brief description on Collective IP’s website pins the company as a “global information company focused on curating and connecting innovation to technology enterprises.”
“A novel suite of products provides timely information, insight and analytics enabling greater opportunity identification and due diligence productivity, time compression and cost savings,” the description continues. “Big data capabilities of the Collective IP platform creates a revolutionary knowledge access point to uniquely accelerate the commercial trajectory of innovation towards productization (sic).”
Rubenstein could not be reached for comment on Monday.
Sinopsys Surgical, founded as DCS Surgical and led by Dr. Harry Ross, is a medical device startup developing a minimally invasive surgical procedure for the lacrimal glands, according to descriptions of DCS published by investors DFJ Mercury and High Country Venture on their websites.
Sinopsys raised $1.2 million of a $2.4 million round, according to the SEC filing made on Monday.
Last year, the firm raised at least $109,998 in equity funding.
Ross could not be reached for comment.
Contact Camera Business Writer Alicia Wallace at 303-473-1332 or email@example.com.